Related Experiment Video
Updated: Feb 5, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced
Di Du1, Zhibin Zhou1, Lei Zhu1
1Department of Orthopedics and Trauma Surgery, Changzheng Hospital, the Second Military Medical University, Shanghai, China.
Abstract:
Tumor Necrosis Factor-α (TNF-α)-inhibited osteogenic differentiation of mesenchymal stem cells (MSCs) contributes to impaired bone formation, which plays a central role in the pathogenesis of postmenopausal osteoporosis. However, the exact mechanisms of TNF-α-inhibited osteoblast differentiation have not been fully elucidated. Multiple P2 purinoceptor subtypes are expressed in several species of osteoblasts and are confirmed to regulate bone metabolism. The purpose of this study is to investigate whether P2 purinoceptors are involved in TNF-α-inhibited osteoblast differentiation. This study shows TNF-α increased P2Y2 receptor expression in the differentiation of MSCs into osteoblasts in a noticeable manner. Overexpressing or silencing of the P2Y2 receptor either impaired or promoted osteogenic differentiation of MSCs significantly. Silencing of the P2Y2 receptor attenuated the inhibitory effects of TNF-α on osteoblastic differentiation of MSCs. In addition, silencing of the P2Y2 receptor evidently alleviated TNF-α-inhibited MSC proliferation. P2Y2 receptor expression was mechanistically upregulated by TNF-α mainly through extracellular regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling pathways. Overall, our results revealed a novel function of the P2Y2 receptor and suggested suppressing the P2Y2 receptor may be an effective strategy to promote bone formation in estrogen deficiency-induced osteoporosis.
Insights
Tumor Necrosis Factor-α (TNF-α) impairs bone formation by affecting mesenchymal stem cells (MSCs). This study reveals the P2Y2 receptor is key in this process, offering a new target for osteoporosis treatment.
Area of Science:
- Cell Biology
- Biochemistry
- Orthopedics
Background:
- Tumor Necrosis Factor-α (TNF-α) inhibits osteogenic differentiation of mesenchymal stem cells (MSCs), contributing to postmenopausal osteoporosis.
- The precise mechanisms underlying TNF-α-induced inhibition of osteoblast differentiation remain unclear.
- P2 purinoceptors are known regulators of bone metabolism in osteoblasts.
Purpose of the Study:
- To investigate the role of P2 purinoceptors in TNF-α-inhibited osteoblast differentiation.
- To determine if P2Y2 receptor is involved in TNF-α's effects on MSCs.
Main Methods:
- Examined P2Y2 receptor expression during MSC osteogenic differentiation under TNF-α influence.
- Utilized gene overexpression and silencing techniques for P2Y2 receptor.
- Investigated the involvement of ERK and JNK signaling pathways.
Main Results:
- TNF-α significantly increased P2Y2 receptor expression during MSC osteogenic differentiation.
- Modulating P2Y2 receptor expression (overexpression or silencing) altered MSC osteogenic differentiation.
- Silencing P2Y2 receptor counteracted TNF-α's inhibitory effects on osteoblast differentiation and MSC proliferation.
- TNF-α upregulated P2Y2 receptor expression via ERK and JNK signaling pathways.
Conclusions:
- P2Y2 receptor plays a critical role in TNF-α-inhibited osteogenic differentiation of MSCs.
- Targeting P2Y2 receptor may offer a therapeutic strategy for osteoporosis, particularly in estrogen deficiency-induced cases.
More Related Videos
08:02Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Accelerators
The effectiveness of calcium chloride can...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors
Internal Receptors
Average Acceleration